Welcome to the InfoSci Platform
Ethical Considerations and Challenges in Neurodegenerative Diseases Using Machine Learning

Ethical Considerations and Challenges in Neurodegenerative Diseases Using Machine Learning

Moushumi Das, Hitakshi Hitakshi, Vandana Mohindru Sood, Kamal Deep Garg, Sushil Kumar Narang
Copyright: © 2024 |Pages: 23
ISBN13: 9798369312810|EISBN13: 9798369312827
DOI: 10.4018/979-8-3693-1281-0.ch011
Cite Chapter Cite Chapter

MLA

Das, Moushumi, et al. "Ethical Considerations and Challenges in Neurodegenerative Diseases Using Machine Learning." Deep Learning Approaches for Early Diagnosis of Neurodegenerative Diseases, edited by Raul Villamarin Rodriguez, et al., IGI Global, 2024, pp. 234-256. https://doi.org/10.4018/979-8-3693-1281-0.ch011

APA

Das, M., Hitakshi, H., Sood, V. M., Garg, K. D., & Narang, S. K. (2024). Ethical Considerations and Challenges in Neurodegenerative Diseases Using Machine Learning. In R. Rodriguez, H. Kannan, R. T., K. Shaikh, & S. Bekal (Eds.), Deep Learning Approaches for Early Diagnosis of Neurodegenerative Diseases (pp. 234-256). IGI Global. https://doi.org/10.4018/979-8-3693-1281-0.ch011

Chicago

Das, Moushumi, et al. "Ethical Considerations and Challenges in Neurodegenerative Diseases Using Machine Learning." In Deep Learning Approaches for Early Diagnosis of Neurodegenerative Diseases, edited by Raul Villamarin Rodriguez, et al., 234-256. Hershey, PA: IGI Global, 2024. https://doi.org/10.4018/979-8-3693-1281-0.ch011

Export Reference

Mendeley
Favorite

Abstract

Neurodegenerative illnesses, some of the most common diseases affecting public health, are affecting an increasing number of nations on a daily basis. Alzheimer's disease (AD) and other neurodegenerative disorders, such as Parkinson's disease (PD) and Huntington's disease (HD), cause gradual declines in cognitive, motor, emotional, and functional abilities and have a significant impact on activities of daily life (ADL) and quality of life. Because of major improvements in digital technology over the last 10 years, digital endpoints may now be integrated into clinical trials to change how neurodegenerative symptoms are diagnosed and tracked. A few additional challenges must be considered to protect those interests. In this chapter, the moral and legal difficulties surrounding the use of technology-assisted treatment for neurodegenerative disorders will be discussed along with a new technique using machine learning algorithms that would work upon the prevailing challenges and come out with better results.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.